Lyrinel XL use in children

The licence for Lyrinel XL (oxybutynin prolonged release) has been extended to include use in children over six years. Previously, use in children under 18 years was not recommended.

The recommended starting dose for children over six years is 5mg once daily, increasing by 5mg increments up to a maximum of 15mg once daily. The safety and efficacy of Lyrinel XL has not been established in patients under six years.

Further information: Janssen-Cilag Ltd 01494 567444

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

New rapidly acting insulin launched

New rapidly acting insulin launched

Lyumjev is a new 'ultra rapidly acting' formulation...

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Statin prescribing 'commonly breaching NICE guidance'

Statin prescribing 'commonly breaching NICE guidance'

Prescribing of suboptimal statin regimens is 'extremely...